Features/News

VAP Cholesterol Test from
Atherotech Covers an Additional
9 Million of Florida Insured
LEARN MORE

Sign up for a Web Seminar on Advanced Lipid Testing.
LEARN MORE


THE VAP TEST
TREATMENT GUIDE
CASE HISTORIES
CLINICAL UPDATES
LITERATURE &
PUBLICATIONS

WELLNESS PARTNERS
HOMOCYSTEINE
& CRP TESTS

EVENTS
NEWS
CME / EDUCATION
LICENSES &
ACCREDITATIONS

CME / Education

VAP Web Seminars
 

The following Web Seminars are scheduled to educate and inform healthcare clinicians about different topics of advanced lipid testing. Please note the following seminars are not CME.

August 29    General overview of the VAP cholesterol test. – How the results determine risk and aid in therapeutic selection.

September 12    General overview of the VAP cholesterol test. – How the results determine risk and aid in therapeutic selection.

September 19    DIACOR – The effects of combination versus monotherapy in diabetic patients. Implications in lipid management and future trends.

October 3    Utilizing the VAP cholesterol test to identify patients at increased risk despite normal cholesterol results – an IVUS substudy of the Diabetes Genome Project (DGP).

October 17    New current consensus guidelines for the utilization of LDL cholesterol, nonHDL cholesterol, and apolipoprotein B100 (apoB) – What does this mean for healthcare?
 

All seminars will be scheduled for 1pm -1:30pm EST
 

Fill out this form if you would like to register for a Web Seminar.
 

First Name:
Last Name:
City:
State:
Email Address:
Phone:
 
Seminar you would like to attend:
 

August 29    General overview of the VAP cholesterol test. – How the results determine risk and aid in therapeutic selection.

September 12    General overview of the VAP cholesterol test. – How the results determine risk and aid in therapeutic selection.

September 19    DIACOR – The effects of combination versus monotherapy in diabetic patients. Implications in lipid management and future trends.

October 3    Utilizing the VAP cholesterol test to identify patients at increased risk despite normal cholesterol results – an IVUS substudy of the Diabetes Genome Project (DGP).

October 17    New current consensus guidelines for the utilization of LDL cholesterol, nonHDL cholesterol, and apolipoprotein B100 (apoB) – What does this mean for healthcare?
 


 

Interested in CME?

If so, please Contact Us to learn more about the educational opportunities provided by Atherotech.


Home | Contact Us | Privacy Policy |  © 2008 Atherotech